{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:11:49Z","timestamp":1791573109480,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Research Project of Anhui Provincial Department of Education","award":["2022AH051240"],"award-info":[{"award-number":["2022AH051240"]}]},{"name":"Health research project of Anhui Province","award":["AHWJ2023A10147"],"award-info":[{"award-number":["AHWJ2023A10147"]}]},{"name":"Health research project of Anhui Province","award":["AHWJ2024Aa30250"],"award-info":[{"award-number":["AHWJ2024Aa30250"]}]},{"name":"Key Scientific Research Fund Project of Wannan Medical College","award":["WK2023ZZD39"],"award-info":[{"award-number":["WK2023ZZD39"]}]},{"name":"Climbing Scientific Peak Project for Talents, The Second Affiliated Hospital of Wannan Medical College","award":["DFJH2022013"],"award-info":[{"award-number":["DFJH2022013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00335-026-10225-4","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:44:32Z","timestamp":1777283072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oncogenic role of LncRNA DLEU2 in thyroid cancer through a NAT10\/USP39 regulatory axis"],"prefix":"10.1007","volume":"37","author":[{"given":"Jiwen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7413-0238","authenticated-orcid":false,"given":"Zhiyong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"10225_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100783","volume":"13","author":"Y Cao","year":"2020","unstructured":"Cao Y, Yao M, Wu Y, Ma N, Liu H, Zhang B (2020) N-acetyltransferase 10 promotes micronuclei formation to activate the senescence-associated secretory phenotype machinery in colorectal cancer cells. Transl Oncol 13:100783. https:\/\/doi.org\/10.1016\/j.tranon.2020.100783","journal-title":"Transl Oncol"},{"key":"10225_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0095-0","volume":"4","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, He C, Wang M, Ma X, Mo F, Yang S et al (2019) Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther 4:62. https:\/\/doi.org\/10.1038\/s41392-019-0095-0","journal-title":"Signal Transduct Target Ther"},{"key":"10225_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3343\/kjlm.2008.28.4.293","volume":"28","author":"TY Choi","year":"2008","unstructured":"Choi TY, Kang JO, Chung SR, Ahn Y (2008) Chlamydia trachomatis antibody in Fitz-Hugh-Curtis syndrome. Korean J Lab Med 28:293\u2013298. https:\/\/doi.org\/10.3343\/kjlm.2008.28.4.293","journal-title":"Korean J Lab Med"},{"key":"10225_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4018","volume":"42","author":"D Darmadi","year":"2024","unstructured":"Darmadi D, Chugaeva UY, Saleh RO, Hjazi A, Saleem HM, Ghildiyal P et al (2024) Critical roles of long noncoding RNA H19 in cancer. Cell Biochem Funct 42:e4018. https:\/\/doi.org\/10.1002\/cbf.4018","journal-title":"Cell Biochem Funct"},{"key":"10225_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.21147\/j.issn.1000-9604.2019.01.09","volume":"31","author":"L Du","year":"2019","unstructured":"Du L, Li R, Ge M, Wang Y, Li H, Chen W et al (2019) Incidence and mortality of thyroid cancer in China, 2008\u20132012. Chin J Cancer Res 31:144\u201351. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.01.09","journal-title":"Chin J Cancer Res"},{"key":"10225_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111093","volume":"133","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Dashti S, Farsi M, Taheri M (2021) Deleted in lymphocytic leukemia 2 (DLEU2): an lncRNA with dissimilar roles in different cancers. Biomed Pharmacother 133:111093. https:\/\/doi.org\/10.1016\/j.biopha.2020.111093","journal-title":"Biomed Pharmacother"},{"key":"10225_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109272","volume":"118","author":"Y Guo","year":"2019","unstructured":"Guo Y, Bai M, Lin L, Huang J, An Y, Liang L et al (2019) LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomed Pharmacother 118:109272. https:\/\/doi.org\/10.1016\/j.biopha.2019.109272","journal-title":"Biomed Pharmacother"},{"key":"10225_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02074-9","volume":"21","author":"S Han","year":"2021","unstructured":"Han S, Qi Y, Xu Y, Wang M, Wang J, Wang J et al (2021) LncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p. Cancer Cell Int 21:376. https:\/\/doi.org\/10.1186\/s12935-021-02074-9","journal-title":"Cancer Cell Int"},{"key":"10225_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03362-2","volume":"44","author":"L Huang","year":"2025","unstructured":"Huang L, Lu Y, He R, Guo X, Zhou J, Fu Z et al (2025) N(4)-acetylcytidine modification of ITGB5 mRNA mediated by NAT10 promotes perineural invasion in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res 44:103. https:\/\/doi.org\/10.1186\/s13046-025-03362-2","journal-title":"J Exp Clin Cancer Res"},{"key":"10225_CR10","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1038\/sj.onc.1201643","volume":"15","author":"Y Liu","year":"1997","unstructured":"Liu Y, Corcoran M, Rasool O, Ivanova G, Ibbotson R, Grander D et al (1997) Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15:2463\u201373. https:\/\/doi.org\/10.1038\/sj.onc.1201643","journal-title":"Oncogene"},{"key":"10225_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109650","volume":"123","author":"T Lu","year":"2020","unstructured":"Lu T, Wang R, Cai H, Cui Y (2020) Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p\/E2F7 axis. Biomed Pharmacother 123:109650. https:\/\/doi.org\/10.1016\/j.biopha.2019.109650","journal-title":"Biomed Pharmacother"},{"key":"10225_CR12","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/emboj\/20.10.2553","volume":"20","author":"OV Makarova","year":"2001","unstructured":"Makarova OV, Makarov EM, Luhrmann R (2001) The 65 and 110 kDa SR-related proteins of the U4\/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes. EMBO J 20:2553\u20132563. https:\/\/doi.org\/10.1093\/emboj\/20.10.2553","journal-title":"EMBO J"},{"key":"10225_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-123","volume":"13","author":"L Morenos","year":"2014","unstructured":"Morenos L, Chatterton Z, Ng JL, Halemba MS, Parkinson-Bates M, Mechinaud F et al (2014) Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a\/16\u2009\u2212\u20091. Mol Cancer 13:123. https:\/\/doi.org\/10.1186\/1476-4598-13-123","journal-title":"Mol Cancer"},{"key":"10225_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3651051","volume":"2020","author":"Y Rao","year":"2020","unstructured":"Rao Y, Liu H, Yan X, Wang J (2020) In silico analysis identifies differently expressed lncrnas as novel biomarkers for the prognosis of thyroid cancer. Comput Math Methods Med 2020:3651051. https:\/\/doi.org\/10.1155\/2020\/3651051","journal-title":"Comput Math Methods Med"},{"key":"10225_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154990","volume":"253","author":"P Rodrigues","year":"2024","unstructured":"Rodrigues P, Bangali H, Ali E, Nauryzbaevish AS, Hjazi A, Fenjan MN et al (2024) The mechanistic role of NAT10 in cancer: unraveling the enigmatic web of oncogenic signaling. Pathol Res Pract 253:154990. https:\/\/doi.org\/10.1016\/j.prp.2023.154990","journal-title":"Pathol Res Pract"},{"key":"10225_CR16","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J et al (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77:1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021","journal-title":"J Hepatol"},{"key":"10225_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-019-1341-x","volume":"571","author":"I Sarropoulos","year":"2019","unstructured":"Sarropoulos I, Marin R, Cardoso-Moreira M, Kaessmann H (2019) Developmental dynamics of lncRNAs across mammalian organs and species. Nature 571:510\u201314. https:\/\/doi.org\/10.1038\/s41586-019-1341-x","journal-title":"Nature"},{"key":"10225_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"10225_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bbrc.2018.04.047","volume":"499","author":"Y Tan","year":"2018","unstructured":"Tan Y, Zheng J, Liu X, Lu M, Zhang C, Xing B et al (2018) Loss of nucleolar localization of NAT10 promotes cell migration and invasion in hepatocellular carcinoma. Biochem Biophys Res Commun 499:1032\u201338. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.047","journal-title":"Biochem Biophys Res Commun"},{"key":"10225_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3892\/ijo.2019.4818","volume":"55","author":"L Wang","year":"2019","unstructured":"Wang L, Chen T, Li X, Yan W, Lou Y, Liu Z et al (2019) USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance. Int J Oncol 55:277\u201388. https:\/\/doi.org\/10.3892\/ijo.2019.4818","journal-title":"Int J Oncol"},{"key":"10225_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2019.02.015","volume":"449","author":"J Wu","year":"2019","unstructured":"Wu J, Chen Y, Geng G, Li L, Yin P, Nowsheen S et al (2019) USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2. Cancer Lett 449:114\u201324. https:\/\/doi.org\/10.1016\/j.canlet.2019.02.015","journal-title":"Cancer Lett"},{"key":"10225_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.749171","volume":"12","author":"KX Wu","year":"2021","unstructured":"Wu KX, Wang XT, Hu XL, Jiang XY, Zhuang JC, Xu YZ et al (2021) LncRNA-ENST00000421645 upregulates Kank1 to inhibit IFN-\u03b3 expression and promote T cell apoptosis in neurosyphilis. Front Microbiol 12:749171. https:\/\/doi.org\/10.3389\/fmicb.2021.749171","journal-title":"Front Microbiol"},{"key":"10225_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.omtn.2023.03.023","volume":"32","author":"L Xie","year":"2023","unstructured":"Xie L, Zhong X, Cao W, Liu J, Zu X, Chen L (2023) Mechanisms of NAT10 as ac4C writer in diseases. Mol Ther Nucleic Acids 32:359\u2013368. https:\/\/doi.org\/10.1016\/j.omtn.2023.03.023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10225_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/cas.13987","volume":"110","author":"B Xu","year":"2019","unstructured":"Xu B, Gong X, Zi L, Li G, Dong S, Chen X et al (2019) Silencing of DLEU2 suppresses pancreatic cancer cell proliferation and invasion by upregulating microRNA-455. Cancer Sci 110:1676\u201385. https:\/\/doi.org\/10.1111\/cas.13987","journal-title":"Cancer Sci"},{"key":"10225_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-019-1308-7","volume":"36","author":"C Yan","year":"2019","unstructured":"Yan C, Yuan J, Xu J, Zhang G, Li X, Zhang B et al (2019) Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53\/p21 pathway and EMT. Med Oncol 36:95. https:\/\/doi.org\/10.1007\/s12032-019-1308-7","journal-title":"Med Oncol"},{"key":"10225_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EC-21-0046","volume":"10","author":"J Yang","year":"2021","unstructured":"Yang J, Huang Y, Dong B, Dai Y (2021) Long noncoding RNA DLEU2 drives the malignant behaviors of thyroid cancer through mediating the miR-205-5p\/TNFAIP8 axis. Endocr Connect 10:471\u2013483. https:\/\/doi.org\/10.1530\/EC-21-0046","journal-title":"Endocr Connect"},{"key":"10225_CR27","doi-asserted-by":"publisher","first-page":"13167","DOI":"10.1007\/s13277-016-5212-x","volume":"37","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Zhang B, Lei Y, Sun J, Zhang Y, Yang S et al (2016) Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma. Tumour Biol 37:13167\u201376. https:\/\/doi.org\/10.1007\/s13277-016-5212-x","journal-title":"Tumour Biol"},{"key":"10225_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023334","volume":"9","author":"L Zhao","year":"2019","unstructured":"Zhao L, Pang P, Zang L, Luo Y, Wang F, Yang G et al (2019) Features and trends of thyroid cancer in patients with thyroidectomies in Beijing, China between 1994 and 2015: a retrospective study. BMJ Open 9:e023334. https:\/\/doi.org\/10.1136\/bmjopen-2018-023334","journal-title":"BMJ Open"},{"key":"10225_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06210-3","volume":"14","author":"J Zheng","year":"2023","unstructured":"Zheng J, Wu S, Tang M, Xi S, Wang Y, Ren J et al (2023) USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6\/HNRNPC. Cell Death Dis 14:670. https:\/\/doi.org\/10.1038\/s41419-023-06210-3","journal-title":"Cell Death Dis"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10225-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-026-10225-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-026-10225-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:44:33Z","timestamp":1777283073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-026-10225-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10225"],"URL":"https:\/\/doi.org\/10.1007\/s00335-026-10225-4","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study involving patients was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the First Affiliated Hospital of Wannan Medical College (WNMC-IRB-2025045). Written informed consent was obtained from all patients. All animal experiments have been carried out in accordance with the National Institutes of Health Guide for the care and the protocol was approved by the Ethics Committee of the First Affiliated Hospital of Wannan Medical College (WNMC-IRB-2025045).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"61"}}